Literature DB >> 8224632

Pyxigraphic sampling to enumerate methanogens and anaerobes in the right colon of healthy humans.

P Pochart1, F Lémann, B Flourié, P Pellier, I Goderel, J C Rambaud.   

Abstract

BACKGROUND: A major limitation in studying the proximal human colonic flora is the lack of suitable sampling methods. The aim of this study was (1) to describe a prototype technique, pyxigraphy, which uses swallowed capsules containing a mechanism allowing the remote control of sampling the gastrointestinal tract contents, and (2) to use this sampling method to examine the distribution of methanogens in the colon of methane (CH4) excretors and non-CH4 excretors.
METHODS: In six CH4 excretors and four non-CH4 excretors, samples of the right colonic contents were obtained by means of the pyxigraphic sampling method. Methanogens and total anaerobes were enumerated in both the right colonic and fecal contents.
RESULTS: In CH4 excretors, the concentration of methanogens was higher in the feces than in the right colonic contents, representing 12% and 0.003%, respectively, of the total anacrobes (P < 0.02). In non-CH4 excretors, no difference was observed, methanogens representing < 0.003% of the total anaerobes in both the right colonic and fecal contents.
CONCLUSIONS: Pyxigraphy is a noninvasive, simple, and safe sampling method that allows to study the microbial populations of the proximal colon. The results obtained showed that methanogens preferentially colonize the distal part of the colon in CH4 excretors.

Entities:  

Mesh:

Year:  1993        PMID: 8224632     DOI: 10.1016/0016-5085(93)90129-z

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  19 in total

1.  Quantification of bacterial groups within human fecal flora by oligonucleotide probe hybridization.

Authors:  A Sghir; G Gramet; A Suau; V Rochet; P Pochart; J Dore
Journal:  Appl Environ Microbiol       Date:  2000-05       Impact factor: 4.792

2.  Comparative study of bacterial groups within the human cecal and fecal microbiota.

Authors:  P Marteau; P Pochart; J Doré; C Béra-Maillet; A Bernalier; G Corthier
Journal:  Appl Environ Microbiol       Date:  2001-10       Impact factor: 4.792

Review 3.  Archaea and the human gut: new beginning of an old story.

Authors:  Nadia Gaci; Guillaume Borrel; William Tottey; Paul William O'Toole; Jean-François Brugère
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

4.  Intestinal methane production in obese individuals is associated with a higher body mass index.

Authors:  Robert J Basseri; Benjamin Basseri; Mark Pimentel; Kelly Chong; Adrienne Youdim; Kimberly Low; Laura Hwang; Edy Soffer; Christopher Chang; Ruchi Mathur
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-01

5.  Acute gastric injury after ingestion of substrate with hyperosmolar glucose and benzoate inversely related with small intestinal bacterial overgrowth.

Authors:  Yeon Ji Kim; Chang Nyol Paik; Ji-Min Lee; Dae Bum Kim; Jin Mo Yang
Journal:  Turk J Gastroenterol       Date:  2020-06       Impact factor: 1.852

Review 6.  Gas and the microbiome.

Authors:  Mark Pimentel; Ruchi Mathur; Christopher Chang
Journal:  Curr Gastroenterol Rep       Date:  2013-12

7.  Relations between transit time, fermentation products, and hydrogen consuming flora in healthy humans.

Authors:  L El Oufir; B Flourié; S Bruley des Varannes; J L Barry; D Cloarec; F Bornet; J P Galmiche
Journal:  Gut       Date:  1996-06       Impact factor: 23.059

8.  Methane production during lactulose breath test is associated with gastrointestinal disease presentation.

Authors:  Mark Pimentel; Andrew G Mayer; Sandy Park; Evelyn J Chow; Aliya Hasan; Yuthana Kong
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

9.  Inhibition of methanogenesis by human bile.

Authors:  T H Florin; H J Woods
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

Review 10.  Methane and the gastrointestinal tract.

Authors:  Ara B Sahakian; Sam-Ryong Jee; Mark Pimentel
Journal:  Dig Dis Sci       Date:  2009-10-15       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.